|
|
||||||||
Vol. 54, Issue 3, 375-430, September 2002
Inotek Pharmaceutical Corp., Beverly, Massachusetts (L.V.,
C.S.); Department of Medical Chemistry, Medical and Health Science
Center, University of Debrecen, Debrecen, Hungary (L.V.); and Institute
of Human Physiology and Clinical Experimental Research, Semmelweis
University, Budapest, Hungary (C.S.)
I. Poly(ADP-Ribose) Metabolism
A. Structure and Function of PARP-1
B. PARP Homologs
Tankyrase-1.
C. Poly(ADP-Ribose) Catabolism: Poly(ADP-Ribose) Glycohydrolase
D. PARP in DNA Repair
E. PARP-1 in Cell Death
1. Apoptosis.
2. Necrosis.
3. Complex Role of PARP-1 in DNA Damage-Induced Cell Death.
F. PARP-1 in the Regulation of Cell Proliferation and
Differentiation
G. PARP in the Regulation of Gene Expression
II. Pharmacological Inhibition of PARP
III. Beneficial Effects of PARP Inhibition in Various
Pathophysiological States
A. Activation of PARP in Pathophysiological Conditions
B. PARP Activation and Cell Necrosis: Implications for
Pathophysiology
C. PARP and Proinflammatory Signal Transduction: Implications for
Pathophysiology
D. PARP in Myocardial Reperfusion Injury
E. PARP in the Pathogenesis of Cardiomyopathy and Toxic Myocardial
Injury
F. PARP in Stroke
G. PARP in Neurotrauma
H. PARP in Reperfusion Injury of the Gut, Eye, Kidney, and Skeletal
Muscle
I. PARP in Arthritis
J. PARP in Inflammatory Bowel Disease
K. PARP in Inflammatory Diseases of the Central Nervous System:
Allergic Encephalomyelitis to Multiple Sclerosis
L. PARP in Systemic Inflammation and Circulatory Shock
M. PARP in the Pathogenesis of Diabetes
N. PARP in the Pathogenesis of Diabetic Cardiovascular Dysfunction
O. PARP Inhibitors as Adjuvant Therapeutics for the Treatment of
Various Forms of Cancer
P. Antiretroviral Effect of PARP Inhibitors
Q. PARP in the Pathogenesis of Other Diseases
IV. Conclusions and Future Directions
Acknowledgments
References
Poly(ADP-ribose) polymerase-1 (PARP-1) is a
member of the PARP enzyme family consisting of PARP-1 and several
recently identified novel poly(ADP-ribosylating) enzymes. PARP-1 is an
abundant nuclear protein functioning as a DNA nick-sensor enzyme. Upon
binding to DNA breaks, activated PARP cleaves NAD+ into
nicotinamide and ADP-ribose and polymerizes the latter onto nuclear
acceptor proteins including histones, transcription factors, and PARP
itself. Poly(ADP-ribosylation) contributes to DNA repair and to the
maintenance of genomic stability. On the other hand, oxidative
stress-induced overactivation of PARP consumes NAD+ and
consequently ATP, culminating in cell dysfunction or necrosis. This
cellular suicide mechanism has been implicated in the pathomechanism of
stroke, myocardial ischemia, diabetes, diabetes-associated cardiovascular dysfunction, shock, traumatic central nervous system injury, arthritis, colitis, allergic encephalomyelitis, and various other forms of inflammation. PARP has also been shown to associate with
and regulate the function of several transcription factors. Of special
interest is the enhancement by PARP of nuclear factor
B-mediated
transcription, which plays a central role in the expression of
inflammatory cytokines, chemokines, adhesion molecules, and inflammatory mediators. Herein we review the double-edged sword roles
of PARP in DNA damage signaling and cell death and summarize the
underlying mechanisms of the anti-inflammatory effects of PARP
inhibitors. Moreover, we discuss the potential use of PARP inhibitors
as anticancer agents, radiosensitizers, and antiviral agents.
This article has been cited by other articles:
![]() |
C.-P. Lin, Y. Ban, Y. L. Lyu, S. D. Desai, and L. F. Liu A Ubiquitin-Proteasome Pathway for the Repair of Topoisomerase I-DNA Covalent Complexes J. Biol. Chem., July 25, 2008; 283(30): 21074 - 21083. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher and C. Szabo Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease Am. J. Pathol., July 1, 2008; 173(1): 2 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Olabisi, N. Soto-Nieves, E. Nieves, T. T. C. Yang, X. Yang, R. Y. L. Yu, H. Y. Suk, F. Macian, and C.-W. Chow Regulation of Transcription Factor NFAT by ADP-Ribosylation Mol. Cell. Biol., May 1, 2008; 28(9): 2860 - 2871. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Korkmaz, B. Kurt, I. Yildirim, S. Basal, T. Topal, S. Sadir, and S. Oter Effects of Poly(ADP-Ribose) Polymerase Inhibition in Bladder Damage Caused by Cyclophosphamide in Rats Experimental Biology and Medicine, March 1, 2008; 233(3): 338 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Sauve NAD+ and Vitamin B3: From Metabolism to Therapies J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 883 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Williams, M. Hornig, K. Yaddanapudi, and W. I. Lipkin Hippocampal Poly(ADP-Ribose) Polymerase 1 and Caspase 3 Activation in Neonatal Bornavirus Infection J. Virol., February 15, 2008; 82(4): 1748 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bai, S. M. Houten, A. Huber, V. Schreiber, M. Watanabe, B. Kiss, G. de Murcia, J. Auwerx, and J. M.-d. Murcia Peroxisome Proliferator-activated Receptor (PPAR)-2 Controls Adipocyte Differentiation and Adipose Tissue Function through the Regulation of the Activity of the Retinoid X Receptor/PPAR{gamma} Heterodimer J. Biol. Chem., December 28, 2007; 282(52): 37738 - 37746. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Beneke and A. Burkle Poly(ADP-ribosyl)ation in mammalian ageing Nucleic Acids Res., December 3, 2007; 35(22): 7456 - 7465. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pinnola, N. Naumova, M. Shah, and A. V. Tulin Nucleosomal Core Histones Mediate Dynamic Regulation of Poly(ADP-ribose) Polymerase 1 Protein Binding to Chromatin and Induction of Its Enzymatic Activity J. Biol. Chem., November 2, 2007; 282(44): 32511 - 32519. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Pan, L. Sun, W. Ma, Y. Tang, C. Long, L. Tian, N. Liu, Z. Feng, and J. Zheng Overactivation of poly(adenosine phosphate-ribose) polymerase 1 and molecular events in neuronal injury after deep hypothermic circulatory arrest: study in a rabbit model. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1227 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Radovits, J. Zotkina, L.-N. Lin, T. Bomicke, R. Arif, D. Gero, E. M. Horvath, M. Karck, C. Szabo, and G. Szabo Poly(ADP-Ribose) Polymerase Inhibition Improves Endothelial Dysfunction Induced by Hypochlorite Experimental Biology and Medicine, October 1, 2007; 232(9): 1204 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yanagawa, T. Funasaka, S. Tsutsumi, H. Hu, H. Watanabe, and A. Raz Regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Activities by the Poly(ADP-Ribose) Polymerase Family-14 Cancer Res., September 15, 2007; 67(18): 8682 - 8689. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pagano, I. Metrailler-Ruchonnet, M. Aurrand-Lions, M. Lucattelli, Y. Donati, and C. B. Argiroffo Poly(ADP-ribose) polymerase-1 (PARP-1) controls lung cell proliferation and repair after hyperoxia-induced lung damage Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L619 - L629. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hara, K. Yamada, T. Shibata, H. Osago, T. Hashimoto, and M. Tsuchiya Elevation of Cellular NAD Levels by Nicotinic Acid and Involvement of Nicotinic Acid Phosphoribosyltransferase in Human Cells J. Biol. Chem., August 24, 2007; 282(34): 24574 - 24582. [Abstract] [Full Text] [PDF] |
||||
![]() |
C-F. Su, D. D. Liu, S. J. Kao, and H. I. Chen Nicotinamide abrogates acute lung injury caused by ischaemia/reperfusion Eur. Respir. J., August 1, 2007; 30(2): 199 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aldinucci, G. Gerlini, S. Fossati, G. Cipriani, C. Ballerini, T. Biagioli, N. Pimpinelli, L. Borgognoni, L. Massacesi, F. Moroni, et al. A Key Role for Poly(ADP-Ribose) Polymerase-1 Activity during Human Dendritic Cell Maturation J. Immunol., July 1, 2007; 179(1): 305 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Lee and M. Jung The Nucleoside Analog Sangivamycin Induces Apoptotic Cell Death in Breast Carcinoma MCF7/Adriamycin-resistant Cells via Protein Kinase C{delta} and JNK Activation J. Biol. Chem., May 18, 2007; 282(20): 15271 - 15283. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Albert, C. Cao, K. W. Kim, C. D. Willey, L. Geng, D. Xiao, H. Wang, A. Sandler, D. H. Johnson, A. D. Colevas, et al. Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models Clin. Cancer Res., May 15, 2007; 13(10): 3033 - 3042. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Donawho, Y. Luo, Y. Luo, T. D. Penning, J. L. Bauch, J. J. Bouska, V. D. Bontcheva-Diaz, B. F. Cox, T. L. DeWeese, L. E. Dillehay, et al. ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models Clin. Cancer Res., May 1, 2007; 13(9): 2728 - 2737. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Berger, C. Lau, and M. Ziegler Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1 PNAS, March 6, 2007; 104(10): 3765 - 3770. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Stevens, F. Li, V. R. Drel, O. I. Abatan, H. Kim, D. Burnett, D. Larkin, and I. G. Obrosova Nicotinamide Reverses Neurological and Neurovascular Deficits in Streptozotocin Diabetic Rats J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 458 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Didion, D. A. Kinzenbaw, L. I. Schrader, and F. M. Faraci Heterozygous CuZn Superoxide Dismutase Deficiency Produces a Vascular Phenotype With Aging Hypertension, December 1, 2006; 48(6): 1072 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Andrabi, N. S. Kim, S.-W. Yu, H. Wang, D. W. Koh, M. Sasaki, J. A. Klaus, T. Otsuka, Z. Zhang, R. C. Koehler, et al. Poly(ADP-ribose) (PAR) polymer is a death signal PNAS, November 28, 2006; 103(48): 18308 - 18313. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Yu, S. A. Andrabi, H. Wang, N. S. Kim, G. G. Poirier, T. M. Dawson, and V. L. Dawson Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death PNAS, November 28, 2006; 103(48): 18314 - 18319. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. An and B. Rodrigues Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Hassa, S. S. Haenni, M. Elser, and M. O. Hottiger Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going? Microbiol. Mol. Biol. Rev., September 1, 2006; 70(3): 789 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Alano, T. M. Kauppinen, A. V. Valls, and R. A. Swanson Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations PNAS, June 20, 2006; 103(25): 9685 - 9690. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ilnytska, V. V. Lyzogubov, M. J. Stevens, V. R. Drel, N. Mashtalir, P. Pacher, M. A. Yorek, and I. G. Obrosova Poly(ADP-Ribose) Polymerase Inhibition Alleviates Experimental Diabetic Sensory Neuropathy Diabetes, June 1, 2006; 55(6): 1686 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Kauppinen, W. Y. Chan, S. W. Suh, A. K. Wiggins, E. J. Huang, and R. A. Swanson Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2 PNAS, May 2, 2006; 103(18): 7136 - 7141. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, S. Huang, Z.-G. Liu, and J. Han Poly(ADP-ribose) Polymerase-1 Signaling to Mitochondria in Necrotic Cell Death Requires RIP1/TRAF2-mediated JNK1 Activation J. Biol. Chem., March 31, 2006; 281(13): 8788 - 8795. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Pillai, A. Isbatan, S.-i. Imai, and M. P. Gupta Poly(ADP-ribose) Polymerase-1-dependent Cardiac Myocyte Cell Death during Heart Failure Is Mediated by NAD+ Depletion and Reduced Sir2{alpha} Deacetylase Activity J. Biol. Chem., December 30, 2005; 280(52): 43121 - 43130. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pagano, C. Pitteloud, C. Reverdin, I. Metrailler-Ruchonnet, Y. Donati, and C. Barazzone Argiroffo Poly(ADP-ribose)polymerase Activation Mediates Lung Epithelial Cell Death In Vitro but Is Not Essential in Hyperoxia-Induced Lung Injury Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 555 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Obrosova, V. R. Drel, P. Pacher, O. Ilnytska, Z. Q. Wang, M. J. Stevens, and M. A. Yorek Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase (PARP) Activation in Experimental Diabetic Neuropathy: The Relation Is Revisited Diabetes, December 1, 2005; 54(12): 3435 - 3441. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Mabley, E. M. Horvath, K. G. K. Murthy, Z. Zsengeller, A. Vaslin, R. Benko, M. Kollai, and C. Szabo Gender Differences in the Endotoxin-Induced Inflammatory and Vascular Responses: Potential Role of Poly(ADP-ribose) Polymerase Activation J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 812 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Berger, C. Lau, M. Dahlmann, and M. Ziegler Subcellular Compartmentation and Differential Catalytic Properties of the Three Human Nicotinamide Mononucleotide Adenylyltransferase Isoforms J. Biol. Chem., October 28, 2005; 280(43): 36334 - 36341. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tapodi, B. Debreceni, K. Hanto, Z. Bognar, I. Wittmann, F. Gallyas Jr., G. Varbiro, and B. Sumegi Pivotal Role of Akt Activation in Mitochondrial Protection and Cell Survival by Poly(ADP-ribose)polymerase-1 Inhibition in Oxidative Stress J. Biol. Chem., October 21, 2005; 280(42): 35767 - 35775. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Palfi, A. Toth, G. Kulcsar, K. Hanto, P. Deres, E. Bartha, R. Halmosi, E. Szabados, L. Czopf, T. Kalai, et al. The Role of Akt and Mitogen-Activated Protein Kinase Systems in the Protective Effect of Poly(ADP-Ribose) Polymerase Inhibition in Langendorff Perfused and in Isoproterenol-Damaged Rat Hearts J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 273 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Farivar, A. S. McCourtie, B. C. MacKinnon-Patterson, S. M. Woolley, A. D. Barnes, M. Chen, P. Jagtap, C. Szabo, C. T. Salerno, and M. S. Mulligan Poly (ADP) Ribose Polymerase Inhibition Improves Rat Cardiac Allograft Survival Ann. Thorac. Surg., September 1, 2005; 80(3): 950 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wang, C. J. Li, P. V. Reddy, and A. B. Pardee Cancer Chemotherapy by Deoxynucleotide Depletion and E2F-1 Elevation Cancer Res., September 1, 2005; 65(17): 7809 - 7814. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Cheng, S. P. Johnson, S. T. Keir, J. A. Quinn, F. Ali-Osman, C. Szabo, H. Li, A. L. Salzman, M. E. Dolan, P. Modrich, et al. Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft Mol. Cancer Ther., September 1, 2005; 4(9): 1364 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, H. Conner, T. Kobayashi, H. Kim, F. Wen, S. Abe, Q. Fang, X. Wang, M. Hashimoto, P. Bitterman, et al. Cigarette Smoke Extract Induces DNA Damage but Not Apoptosis in Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., August 1, 2005; 33(2): 121 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Pieper, V. Nilakantan, M. Chen, J. Zhou, A. K. Khanna, J. D. Henderson Jr., C. P. Johnson, A. M. Roza, and C. Szabo Protective Mechanisms of a Metalloporphyrinic Peroxynitrite Decomposition Catalyst, WW85, in Rat Cardiac Transplants J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 53 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. BOROS, M. NICHELATTI, and Y. SHOENFELD Fermented Wheat Germ Extract (Avemar) in the Treatment of Cancer and Autoimmune Diseases Ann. N.Y. Acad. Sci., June 1, 2005; 1051(1): 529 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. McCullough, Z. Zeng, H. Li, L. E. Landree, J. McFadden, and G. V. Ronnett Pharmacological Inhibition of AMP-activated Protein Kinase Provides Neuroprotection in Stroke J. Biol. Chem., May 27, 2005; 280(21): 20493 - 20502. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Li, V. R. Drel, C. Szabo, M. J. Stevens, and I. G. Obrosova Low-Dose Poly(ADP-Ribose) Polymerase Inhibitor-Containing Combination Therapies Reverse Early Peripheral Diabetic Neuropathy Diabetes, May 1, 2005; 54(5): 1514 - 1522. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cipriani, E. Rapizzi, A. Vannacci, R. Rizzuto, F. Moroni, and A. Chiarugi Nuclear Poly(ADP-ribose) Polymerase-1 Rapidly Triggers Mitochondrial Dysfunction J. Biol. Chem., April 29, 2005; 280(17): 17227 - 17234. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Deng, C. Atanasiu, K. Zhao, R. Marmorstein, J. I. Sbodio, N.-W. Chi, and P. M. Lieberman Inhibition of Epstein-Barr Virus OriP Function by Tankyrase, a Telomere-Associated Poly-ADP Ribose Polymerase That Binds and Modifies EBNA1 J. Virol., April 15, 2005; 79(8): 4640 - 4650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. West, C. Ji, and L. J. Marnett Modulation of DNA Fragmentation Factor 40 Nuclease Activity by Poly(ADP-ribose) Polymerase-1 J. Biol. Chem., April 15, 2005; 280(15): 15141 - 15147. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cuzzocrea, R. Di Paola, E. Mazzon, U. Cortes, T. Genovese, C. Muia, W. Li, W. Xu, J.-H. Li, J. Zhang, et al. PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion FASEB J, April 1, 2005; 19(6): 558 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Hua, H. Albadawi, F. Entabi, M. Conrad, M. C. Stoner, B. T. Meriam, R. Sroufe, S. Houser, G. M. LaMuraglia, and M. T. Watkins Polyadenosine Diphosphate-Ribose Polymerase Inhibition Modulates Skeletal Muscle Injury Following Ischemia Reperfusion Arch Surg, April 1, 2005; 140(4): 344 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Corral, J. Yelamos, D. Hernandez-Espinosa, Y. Monreal, R. Mota, I. Arcas, A. Minano, P. Parrilla, and V. Vicente Role of Lipopolysaccharide and Cecal Ligation and Puncture on Blood Coagulation and Inflammation in Sensitive and Resistant Mice Models Am. J. Pathol., April 1, 2005; 166(4): 1089 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Xiao, M. Chen, Z. Zsengeller, H. Li, L. Kiss, M. Kollai, and C. Szabo Poly(ADP-Ribose) Polymerase Promotes Cardiac Remodeling, Contractile Failure, and Translocation of Apoptosis-Inducing Factor in a Murine Experimental Model of Aortic Banding and Heart Failure J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 891 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Kauppinen and R. A. Swanson Poly(ADP-Ribose) Polymerase-1 Promotes Microglial Activation, Proliferation, and Matrix Metalloproteinase-9-Mediated Neuron Death J. Immunol., February 15, 2005; 174(4): 2288 - 2296. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Szabo, P. Soos, U. Heger, C. Flechtenmacher, S. Bahrle, Z. Zsengeller, C. Szabo, and S. Hagl Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation Eur. J. Cardiothorac. Surg., February 1, 2005; 27(2): 226 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Genovese, E. Mazzon, C. Muia, N. S. A. Patel, M. D. Threadgill, P. Bramanti, A. De Sarro, C. Thiemermann, and S. Cuzzocrea Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and Secondary Damage in Experimental Spinal Cord Trauma J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 449 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Na |